Overview of Helicobacter pylori Infection, Prevalence, Risk Factors, and Its Prevention
Table 3
Prospects in the management of H. pylori infection.
(i) Susceptibility-guided therapy/antibiotic sensitivity testing (ii) PPI-high dose (iii) Novel antibiotics (iv) Clarithromycin avoidance, if used previously (v) Antibiotic course for 14 days (vi) Probiotics with antibiotics (vii) Vonoprazan (P-CAB) instead of PPI (viii) PCR/DNA extraction (from stool sample) for making a diagnosis (ix) Nanotechnology use